Wells Fargo & Company Precigen, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Precigen, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 102,273 shares of PGEN stock, worth $74,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,273
Previous 104,544 2.17%
Holding current value
$74,659
Previous $165,000 41.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.91 - $1.88 $2,066 - $4,269
-2,271 Reduced 2.17%
102,273 $97,000
Q2 2024

Aug 13, 2024
BUY
$1.27 - $1.75 $9,287 - $12,797
7,313 Added 7.52%
104,544 $165,000
Q1 2024

May 10, 2024
SELL
$1.21 - $1.75 $1,643 - $2,376
-1,358 Reduced 1.38%
97,231 $140,000
Q4 2023

Feb 09, 2024
BUY
$0.89 - $1.41 $7,142 - $11,315
8,025 Added 8.86%
98,589 $132,000
Q3 2023

Nov 13, 2023
SELL
$1.08 - $1.85 $15,528 - $26,599
-14,378 Reduced 13.7%
90,564 $128,000
Q2 2023

Aug 15, 2023
BUY
$0.96 - $1.4 $29,449 - $42,947
30,677 Added 41.31%
104,942 $120,000
Q1 2023

May 12, 2023
BUY
$0.88 - $2.19 $10,936 - $27,217
12,428 Added 20.1%
74,265 $78,000
Q4 2022

Feb 13, 2023
SELL
$1.27 - $2.26 $111,085 - $197,679
-87,469 Reduced 58.58%
61,837 $93,000
Q3 2022

Nov 14, 2022
SELL
$1.41 - $2.79 $545 - $1,079
-387 Reduced 0.26%
149,306 $317,000
Q2 2022

Aug 12, 2022
BUY
$1.15 - $2.53 $43,039 - $94,687
37,426 Added 33.34%
149,693 $200,000
Q1 2022

May 16, 2022
SELL
$1.91 - $3.98 $101,394 - $211,282
-53,086 Reduced 32.1%
112,267 $237,000
Q4 2021

Feb 14, 2022
SELL
$3.53 - $5.5 $1.12 Million - $1.74 Million
-316,424 Reduced 65.68%
165,353 $613,000
Q3 2021

Nov 15, 2021
BUY
$4.99 - $6.55 $449,848 - $590,482
90,150 Added 23.02%
481,777 $2.4 Million
Q2 2021

Aug 16, 2021
BUY
$6.24 - $8.22 $237,893 - $313,379
38,124 Added 10.78%
391,627 $2.55 Million
Q1 2021

May 13, 2021
BUY
$6.74 - $10.95 $785,688 - $1.28 Million
116,571 Added 49.2%
353,503 $2.44 Million
Q4 2020

Feb 09, 2021
BUY
$3.75 - $10.56 $47,036 - $132,454
12,543 Added 5.59%
236,932 $2.42 Million
Q3 2020

Nov 05, 2020
SELL
$3.5 - $6.2 $153,454 - $271,832
-43,844 Reduced 16.35%
224,389 $785,000
Q2 2020

Aug 13, 2020
BUY
$2.16 - $5.46 $233,899 - $591,247
108,287 Added 67.7%
268,233 $1.34 Million
Q1 2020

May 14, 2020
BUY
$1.46 - $7.19 $233,521 - $1.15 Million
159,946 New
159,946 $545,000

Others Institutions Holding PGEN

# of Institutions
143
Shares Held
159M
Call Options Held
232K
Put Options Held
69K
View Full List

About PRECIGEN, INC.

PGEN Quotes by TradingView
  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $152M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email